Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 70, Issue 4 , Pages 349-356 , April 2004

Fatty acids and homocysteine levels in patients with recurrent depression: an explorative pilot study

  • J Assies

      Affiliations

    • Department of Psychiatry, Academic Medical Centre, Tafelbergweg 25, Amsterdam 1105BC, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31-20-5669-111; fax: +31-20-697-8519
    • ,
  • A Lok

      Affiliations

    • Department of Psychiatry, Academic Medical Centre, Tafelbergweg 25, Amsterdam 1105BC, The Netherlands
    • ,
  • C.L Bockting

      Affiliations

    • Department of Psychiatry, Academic Medical Centre, Tafelbergweg 25, Amsterdam 1105BC, The Netherlands
    • ,
  • G.J Weverling

      Affiliations

    • Department of Clinical Epidemiology and Biostatistics, Academic Medical Centre, Amsterdam, The Netherlands
    • ,
  • R Lieverse

      Affiliations

    • Department of Psychiatry, GGZ Buitenamstel, Amsterdam, The Netherlands
    • ,
  • I Visser

      Affiliations

    • Netherlands Centre for Occupational Diseases/Coronel Institute for Occupational and Environmental Health, Academic Medical Centre, Amsterdam, The Netherlands
    • ,
  • N.G.G.M Abeling

      Affiliations

    • Laboratory Genetic Metabolic Diseases, Academic Medical Centre, Amsterdam, The Netherlands
    • ,
  • M Duran

      Affiliations

    • Laboratory Genetic Metabolic Diseases, Academic Medical Centre, Amsterdam, The Netherlands
    • ,
  • A.H Schene

      Affiliations

    • Department of Psychiatry, Academic Medical Centre, Tafelbergweg 25, Amsterdam 1105BC, The Netherlands

,Accepted 18 December 2003.

References 

  1. J.F. Graden, The burden of recurrent depression; cause, consequences, and future prospects, J. Clin. Psychiatry 62 (suppl 22) (2001), 5–9.
  2. Murray CJL, Lopez AD. The global burden of disease (a comprehensive assessment of mortality and disability from disease, injuries, and risk facors in 1990 and projected to 2020). Vol. 1. Cambridge, MA: Harvard University Press; 1996;
  3. Rudich B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biol. Psychiatry. 2003;54:227–240
  4. Musselman DL, Evans Dll, Nemeroff CB. The relationship of depression to cardiovascular disease. Epidemiology, Biology, and treatment. Arch. Gen. Psychiatry. 1998;55:580–592
  5. Ariyo AA, Haan AM, Tangen CM, et al.  Depressive symptoms and risks of coronary artery disease and mortaliy in elderly Americans. Circulation. 2000;102:1773–1779
  6. Meigs JB. Invited commentary (insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors). Am. J. Epidemiol. 2000;15:908–911
  7. Emanuel Severus W, Littman AB, Stoll AL. Omega-3 fatty acids, homocysteine, and the increased rik of cardiovascular mortality in major depressive disorder. Harvard Rev. Psychiatry. 2001;9:280–293
  8. Horrobin DF, Bennett CN. Phospholipid metabolism and the pathopysiology of psychiatric and neurological disorders. In:  Peet M,  Glen I,  Horrobin DF editor. Phospholipid Spectrum Disorders in Psychiatry and Neurology. Lancashire: Marius Press; 2003;p. 3–47
  9. J.E. Kinsella, Lipids, membrane receptors, and enzymes: effects of dietary fatty acids, J. Parenter Enteral Nutr. 14 (Suppl 5) (1990) 200S–217S.
  10. Katan MD, Deslypere JP, van Birgelen AP, et al.  Kinetics of incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue (an 18-month controlled study). J. Lipid. Res. 1997;38:2012–2022
  11. Lee KL, Lip GYH. The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease. Q. J. Med. 2003;96:465–480
  12. Hibbeln JR, Salem N. Dietary polyunsaturated fatty acids and depression; when cholesterol does not satisfy. Am. J. Clin. Nutr. 1995;62:1–9
  13. Adams PB, Lawson S, Sanigorski A, et al.  Arachidonic to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids. 1996;31(suppl):S157–S161
  14. Edwards R, Peet M, Shay J, et al.  Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J. Affect Disord. 1998;48:149–155
  15. Peet M, Murphy B, Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol. Psychiatry. 1998;43:315–319
  16. Maes M, Christophe A, Delanghe J, et al.  Lowered omega 3 polyunsaurated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res. 1999;85:275–291
  17. Tiemeier H, van Tuijl HR, Hofman A, et al.  Plasma fatty acid composition and depression are associated in the elderly (the Rotterdam study). Am. J. Clin. Nutr. 2003;78:40–46
  18. Delafuente M, Fernandez MD, Burgos MS. Immune function in aged women is improved by ingestion of vitamins C E. Can. J. Physiol. Pharmacol. 1998;76:373–380
  19. Heinecke JW. Is lipid peroxidation relevant to atherogenesis?. J. Clin. Invest. 1999;104:135–136
  20. Selhub J. Homocysteine metabolism. Ann. Rev. Nutr. 1999;19:217–246
  21. Loscalzo J. The oxidant stress of hyperhomocysteinemia. J. Clin. Invest. 1996;98:5–7
  22. Bousshey CJ, Bersford SA, Omenn GS. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease (probable benefits of increasing folic acid intakes). JAMA. 1995;274:1049–1057
  23. Fava M, Borus JS, Alpert JA. Folate, vitamin B12, and homocysteine in major depressive disorder. Am. J. Psychiatry. 1997;154:426–428
  24. Bottiglieri T, Laundy M, Crellin R, et al.  Homocysteine, folate, methylation, and monoamine metabolism in depression. J. Neurol. Neurosurg. Psychiatry. 2000;69:228–232
  25. Durand P, Prost M, Blanche D. Pro-thrombotic effects of a folic acid deficient diet in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids. Atheroclerosis. 1996;121:231–243
  26. Pita ML, Delgado MJ. Folate administation increases n-3 polyunsaturated fatty acids in rat plasma and tissue lipids. Thromb. Haemost. 2000;84:420–423
  27. Bohles H, Arndt S, Ohlenschlager U, et al.  Maternal plasma homocysteine, placenta status and docosahexaenoic acid concentration in erythrocyte phospholipids of the newborn. Eur. J. Pediatr. 1999;158:243–246
  28. Bhagwager Z, Hafizi S, Cowen PJ. Increase in concentration of waking salivary cortisol in recovered patients with depression. Am. J. Psychiatry. 2003;160:1890–1891
  29. Holm SA. A simple sequentially rejective multiple test procedure. Scand. J. Stat. 1979;6(65):65–70
  30. R.R. Brenner, Hormonal modulation of Δ6 and Δ6 desaturases: case of diabetes, Prostaglandins Leukot. Essent. Fatty Acids (2003) 151–162.
  31. Halliwell B, Gutteridge JM. Free radicals in biology and medicine. 3rd Edition. Oxford: Oxford University Press; 1998;
  32. Spiteller G. Are lipid peroxidation processes induced by changes in cell wall structure and how are these processes connected with disease?. Med. Hypoth. 2003;60(1):69–83
  33. Simopoulos AP. Omega 3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutrition. 2002;21/6:495–505
  34. Maes M, De Vos N, Pioli R, Demedts P, Wauters A, Neels H, et al. Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J. Affective Dis. 2000;58:241–246
  35. Bilici M, Efe H, Koroglu A, Avni Uydu H, Bekaroglu M, Deger O. Antioxidative activities in major depression (alterations by antidepressant treatment). J. Affective Dis. 2001;64:43–51
  36. Assies J, Lieverse R, Vreken P, et al.  Significantly reduced docosahexaenoic acid and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol. Psychiatry. 2001;49:510–522
  37. Khan MM, Evans DR, Gunna V, et al.  Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophrenia Res. 2002;58:1–10
  38. Gutteridge JM, Quinlan GJ, Yamamoto Y. Are fatty acid patterns characteristic of essential fatty acid deficiency indicative of oxidative stress?. Free Rad. Res. 1998;28:109–114
  39. R. Pamplona, G. Barja, M. Portero-Otin, Membrane fatty acid unsaturation, protection against oxidative stres, and maximum life span. A homeoviscous-longevity adaptation? Ann. N. Y. Acad. Sci. 959 (2002) 475–490.
  40. Yavin E, Brand A, Green P. Docosahexaenoic acid abundance in the brain (a biodevice to combat oxidative stress). Nutr. Neurosci. 2002;5(3):149–157
  41. Palozza P, Sgarlata E, Luberto C, Piccioni E, Anti M, Marra G, et al. N-3 Fatty acids induce oxidative modifications in human erythrocytes depending on dose and duration of dietary supplementation. Am. J. Clin. Nutrition. 1996;64:297–304
  42. Whatley SA, Curti D, Marchbank RM. Mitochondrial involvement in schizophrenia and other functional psychoses. Neurochem. Res. 1996;21/6:995–1004
  43. Gardner A, Johansson A, Wibom R, Nennesmo I, Dobeln U, Hagenfeldt L, et al. Affections of mitochondrial function and correlations with personality traits in selected depressive disorder patients. J. Affect Disord. 2003;76(1–3):55–68

PII: S0952-3278(04)00005-5

doi: 10.1016/j.plefa.2003.12.009

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 70, Issue 4 , Pages 349-356 , April 2004

Article Tools